Table 3 PRL levels and clinical features of seven “no-responder” and ten “responder” patients of the group A
From: Relationship between high prolactine levels and migraine attacks in patients with microprolactinoma
Group A | ||
|---|---|---|
No-responders | Responders | |
No. (%) | 7 (41) | 10 (59) |
PRL basal (ng/mL) | 127 ± 21.4 | 101.5 ± 10.6 |
PRL during headachesa (ng/mL) | 136.8 ± 19.8 | 205.6 ± 13.7 |
No. of patients with “positive response” after TRH-test | 0/10 | 5/10 |
PRL after TRH-test (ng/mL) | 144.8 ± 10.6 | 198.4 ± 8.6 |
PRL after DA treatment (ng/mL) | 82 ± 5.4 | 67.5 ± 9.2 |
Outcome of headache after DA therapy, No. (%) | ||
a (improvement) | 3/7 (43) | 5/10 (50) |
b (worsening) | 1/7 (14) | 1/10 (10) |
c (unchanged) | 0/7 (0) | 3/10 (30) |
d (changed characteristics) | 3/7 (43) | 1/10 (10) |